深圳市海王英特龙生物技术股份有限公司（08329）于2026年2月2日披露2026年1月的股份变动月报。报告期为2026年1月1日至1月31日，公司注册股本为人民币42,600,000元，较上月无变化。
报告显示，H股已发行股份数量为426,000,000股，其余类别股份合计1,252,000,000股，两项与上月保持一致。本月无新增发行、购回或注销股份行为，也无库藏股变动。
公司未披露任何股份期权或股权激励计划变动，亦未进行购回及注销活动。截至本月末，公司股份总数保持稳定，且已确认符合香港联交所的公众持股量要求。
公告由卓佳证券登记有限公司以H股股份过户及登记处名义呈交。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.